Envue Medical Inc (FEED)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,333 | -5,843 | -2,495 | -3,705 | -2,274 |
| Depreciation Amortization | 639 | 382 | 18 | 1 | 1 |
| Accounts receivable | -122 | 15 | -228 | 221 | -261 |
| Accounts payable and accrued liabilities | 1,003 | 755 | 565 | 151 | -59 |
| Other Working Capital | 989 | 923 | 555 | 731 | 39 |
| Other Operating Activity | -3,872 | -958 | 242 | 85 | 586 |
| Operating Cash Flow | $-6,696 | $-4,726 | $-1,343 | $-2,516 | $-1,968 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -37 | -9 | -5 | -3 | -3 |
| Net Acquisitions | 148 | 148 | 148 | N/A | N/A |
| Investing Cash Flow | $111 | $139 | $143 | $-3 | $-3 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 360 | 360 | 1,050 | N/A | N/A |
| Debt Issued | 1,300 | 1,300 | N/A | N/A | N/A |
| Debt Repayment | -1,300 | -1,300 | N/A | N/A | 0 |
| Common Stock Issued | 17,237 | 102 | N/A | 1 | 1 |
| Other Financing Activity | -4,777 | 7,438 | 0 | 0 | 0 |
| Financing Cash Flow | $12,820 | $7,900 | $1,050 | $1 | $1 |
| Exchange Rate Effect | -7 | -5 | -1 | -13 | -8 |
| Beginning Cash Position | 752 | 752 | 752 | 3,283 | 3,283 |
| End Cash Position | 6,980 | 4,060 | 601 | 752 | 1,305 |
| Net Cash Flow | $6,228 | $3,308 | $-151 | $-2,531 | $-1,978 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,696 | -4,726 | -1,343 | -2,516 | -1,968 |
| Capital Expenditure | -37 | -9 | -5 | -3 | -3 |
| Free Cash Flow | -6,733 | -4,735 | -1,348 | -2,519 | -1,971 |